EBOS Group Ltd (EBO)

Currency in NZD
40.05
+0.07(+0.18%)
Closed·
EBO Scorecard
Full Analysis
Has raised its dividend for 11 consecutive years
EBO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
39.8540.51
52 wk Range
34.7542.55
Key Statistics
Bid/Ask
40.05 / 40.20
Prev. Close
39.98
Open
39.9
Day's Range
39.85-40.51
52 wk Range
34.75-42.55
Volume
97.68K
Average Volume (3m)
625.31K
1-Year Change
10.16%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EBO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
40.17
Upside
+0.29%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

EBOS Group Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

EBOS Group Ltd Company Profile

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers allografts solutions; healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

Employees
5200

Compare EBO to Peers and Sector

Metrics to compare
EBO
Peers
Sector
Relationship
P/E Ratio
30.3x24.8x−0.5x
PEG Ratio
−5.66−0.140.00
Price/Book
3.0x1.6x2.6x
Price / LTM Sales
0.6x1.4x3.3x
Upside (Analyst Target)
3.5%17.2%45.1%
Fair Value Upside
Unlock16.3%7.4%Unlock

Analyst Ratings

5 Buy
1 Hold
2 Sell
Ratings:
8 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 40.17
(+0.29% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.27%
Dividend Yield
3.09%
Industry Median 3.04%
Annualised payout
1.24
Paid unevenly
5-Years Growth
+8.62%
Growth Streak

Earnings

Latest Release
Feb 19, 2025
EPS / Forecast
0.57 / --
Revenue / Forecast
5.99B / --
EPS Revisions
Last 90 days

EBO Income Statement

People Also Watch

338.99
DUOL
-2.18%
7.60
AIA
+1.33%
250.74
CRM
-2.94%
237.77
UNH
-4.72%
151.40
CVX
-0.16%

FAQ

What Stock Exchange Does EBOS Trade On?

EBOS is listed and trades on the New Zealand Exchange stock exchange.

What Is the Stock Symbol for EBOS?

The stock symbol for EBOS is "EBO."

What Is the EBOS Market Cap?

As of today, EBOS market cap is 8.14B.

What Is EBOS's Earnings Per Share (TTM)?

The EBOS EPS (TTM) is 1.27.

From a Technical Analysis Perspective, Is EBO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has EBOS Stock Split?

EBOS has split 5 times.

How Many Employees Does EBOS Have?

EBOS has 5200 employees.

What is the current trading status of EBOS (EBO)?

As of 04 Aug 2025, EBOS (EBO) is trading at a price of 40.05, with a previous close of 39.98. The stock has fluctuated within a day range of 39.85 to 40.51, while its 52-week range spans from 34.75 to 42.55.

What Is EBOS (EBO) Price Target According to Analysts?

The average 12-month price target for EBOS is NZD40.16712, with a high estimate of NZD45.4 and a low estimate of NZD31.5. 5 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Buy. The stock has an +0.29% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.